Australia · Delayed Price · Currency is AUD Clinuvel Pharmaceuticals Company Description
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP).
The company’s pipeline products include CUV9900 and Parvysmelanotide (VLRX001), both alpha-melanocyte stimulating hormone analogue; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide.
It is also developing NEURACTHEL (ACTH), an adrenocorticotropic hormone to produce cortisol and enables the combat of stress and regulation of immune responses, maintenance of blood pressure, moderation of blood sugar, and regulation of metabolism.
The company was incorporated in 1999 and is headquartered in Melbourne, Australia.
| Country | Australia |
| Founded | 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 16 |
| CEO | Lachlan Hay |
Contact Details
Address: 535 Bourke Street Melbourne, 3000 Australia | |
| Phone | 61 3 9660 4900 |
| Website | clinuvel.com |
Stock Details
| Ticker Symbol | CUV |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000CUV3 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Lachlan Hay | Chief Operating Officer and Acting Chief Executive Officer |
| Dr. Dennis J. Wright BPharm, M.Sc., Ph.D. | Chief Scientific Officer |
| Dr. Philippe Jacques Wolgen M.B.A., M.D. | MD and Director |
| Peter Vaughan | Chief Financial Officer |
| Malcolm Bull | Head of Australian Operations and Investor Relations |
| Dr. Rose Quadbeck-Diel | Senior Vice President of Regulatory Affairs |
| Dr. Azza Hamila | Head of Quality Assurance and Drug Safety |
| Claire Newstead-Sinclair C.A. | Company Secretary |